Published in Blood Weekly, August 10th, 2006
Researchers in Australia conducted a study "to explore the likely optimum BP level for patients with a history of cerebrovascular disease. The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) was a randomized, placebo-controlled trial that established the beneficial effects of BP lowering in 6105 patients with cerebrovascular disease."
H. Arima and colleagues, University of Sydney, wrote, "The present study comprises two series of post hoc analyses. The first was designed to investigate the effects of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.